Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Danimer Scientific, Inc.
  6. Financials
    DNMR   US2362721001

DANIMER SCIENTIFIC, INC.

(DNMR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 2 015855402--
Enterprise Value (EV)1 1 694830402402402
P/E ratio --13,1x-3,88x-4,37x-4,52x
Yield -----
Capitalization / Revenue 42,6x14,6x3,88x2,26x1,49x
EV / Revenue 42,6x14,6x3,88x2,26x1,49x
EV / EBITDA -626x-37,9x-9,46x-27,0x27,2x
Price to Book -----
Nbr of stocks (in thousands) 85 725100 344101 115--
Reference price (USD) 23,58,523,983,983,98
Announcement Date 03/29/202102/28/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023 2024
Net sales1 47,358,7104178270
EBITDA1 -3,22-22,6-42,5-14,914,8
Operating profit (EBIT)1 -12,0-99,5-91,8-65,4-55,8
Operating Margin -25,3%-169%-88,4%-36,7%-20,7%
Pre-Tax Profit (EBT)1 --73,3-104-95,4-96,5
Net income1 --60,1-104-95,4-97,0
Net margin --102%-100%-53,6%-36,0%
EPS2 --0,65-1,03-0,91-0,88
Dividend per Share -----
Announcement Date 03/29/202102/28/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 13,417,714,715,426,333,8
EBITDA1 -7,35-10,2-10,6-12,9-10,4-8,60
Operating profit (EBIT)1 -25,7-35,3-30,7-25,6-23,5-21,9
Operating Margin -192%-199%-208%-166%-89,7%-64,7%
Pre-Tax Profit (EBT)1 -3,60-14,3-26,7-26,4-24,4-26,0
Net income1 7,83-12,4-26,4-26,7-24,7-26,3
Net margin 58,5%-70,2%-179%-174%-94,0%-77,7%
EPS2 0,08-0,12-0,26-0,27-0,25-0,26
Dividend per Share ------
Announcement Date 11/15/202102/28/202205/10/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt -----
Net Cash position 32125,2---
Leverage (Debt / EBITDA) 99,7x1,12x---
Free Cash Flow1 -52,1-248-227-321-147
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex1 -185195169128
Capex / Sales -316%188%94,7%47,4%
Announcement Date 03/29/202102/28/2022---
1 USD in Million
Estimates
Key data
Capitalization (USD) 402 437 146
Net sales (USD) 58 749 000
Number of employees 282
Sales / Employee (USD) 208 330
Free-Float 86,9%
Free-Float capitalization (USD) 349 654 951
Avg. Exchange 20 sessions (USD) 9 587 321
Average Daily Capital Traded 2,38%
EPS & Dividend